Amoy Diagnostics Co., Ltd. (SHE:300685)
China · Delayed Price · Currency is CNY 21.85
-0.16 (-0.73%)
Dec 1, 2025, 3:04 PM CST
Amoy Diagnostics Market Cap
Amoy Diagnostics has a market cap or net worth of 8.51 billion as of November 28, 2025. Its market cap has decreased by -13.56% in one year.
Market Cap
8.51B
Enterprise Value
7.30B
Revenue
1.13B
Ranking
n/a
PE Ratio
29.82
Stock Price
21.85
Market Cap Chart
Since August 2, 2017, Amoy Diagnostics's market cap has increased from 1.60B to 8.51B, an increase of 433.24%. That is a compound annual growth rate of 22.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 8.51B | -5.16% |
| Dec 31, 2024 | 8.98B | 3.50% |
| Dec 29, 2023 | 8.67B | -17.63% |
| Dec 30, 2022 | 10.53B | -37.10% |
| Dec 31, 2021 | 16.74B | -3.54% |
| Dec 31, 2020 | 17.36B | 76.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 412.84B |
| WuXi AppTec | 275.07B |
| Shenzhen Mindray Bio-Medical Electronics | 237.40B |
| Sichuan Biokin Pharmaceutical | 158.95B |
| Shanghai United Imaging Healthcare | 108.33B |
| Aier Eye Hospital Group | 105.97B |
| Zhangzhou Pientzehuang Pharmaceutical., | 105.38B |
| Yunnan Baiyao Group Co.,Ltd | 100.04B |